University of Dundee University of Dundee
Text only
         
Search
 
 
 
 

15 June 2010

University of Dundee First to Install Biacore 4000 SPR System

Enables fast, reliable and cost-effective screening of fragment libraries

Dundee, Scotland, 15th June 2010: The University of Dundee announced today that it has become the first facility worldwide to take delivery of Biacore(tm) 4000. Biacore 4000 is a powerful solution for large-scale, label-free molecular interaction analysis in drug discovery, from early screening to characterization. The University of Dundee and spin-out company Kinetic Discovery Ltd will be using the system to focus on developing biophysical fragment based screening methodologies for efficient drug discovery.

Dr Iva Navratilova, Independent Investigator, University of Dundee and founder of Kinetic Discovery, commented: 'We are developing biosensor based screening methods that enable us to characterise the kinetics and thermodynamics of molecular interactions. The unprecedented combination of high sample capacity and sensitivity provided by Biacore 4000 means we can now carry out highly accurate screening of our fragment library in only a couple of days, rather than the weeks it would have otherwise taken.'

Dr. Navratilova also plans to use Biacore 4000 to continue her work on developing biosensor SPR methods for screening native membrane proteins such as GPCRs, an important class of drug targets. SPR is used to characterise complex kinetic interactions of GPCRs with their natural ligands or low molecular weight inhibitors. The system is designed for large-scale parallel interaction analyses, with the capability to analyze up to 4800 interactions in 24hrs, ideal for running biophysical screening campaigns on selected compound libraries.

Structural methods used for fragment screening present several technical challenges, including consumption of large amounts of target protein, and a requirement for high sample concentrations due to the low (typically micromolar to millimolar) affinities exhibited by fragments, which leads to solubility/non-specific binding issues. SPR-based strategies can be designed to overcome many of these issues, providing an efficient, informative complement to structural methods. The kinetic information obtained can then be used to support further compound optimisation efforts.

'We're very excited to be the first facility to install a Biacore 4000 instrument', said Prof. Andrew Hopkins, Chair of Medicinal Informatics and SULSA Research Professor of Translational Biology, University of Dundee, and CEO of Kinetic Discovery: 'We believe this reinforces our position as a world leader in the field of SPR based fragment screening, and we look forward to seeing the many benefits the purchase will make to our research efforts.'

Notes to editors

About The University of Dundee

The University of Dundee is internationally recognised for its excellence in life sciences and medical research with particular expertise in cancer, diabetes, cardiovascular disease and tropical diseases. The University has a top-rated medical school with research expanding from 'the cell to the clinic to the community', while the College of Life Sciences is home to some of the world's most cited scientists among 800 research staff from 60 different countries. Dundee is also the UK's third highest generator of per capita research income, much of it focussed on medical and life sciences research. See www.dundee.ac.uk for more details.

About Kinetic Discovery

Kinetic Discovery (www.kineticdiscovery.com) offers high quality kinetic analysis and biosensor screening for drug discovery projects. Kinetic Discovery specialises in determining the kinetic profiles of molecular interactions using surface plasmon resonance (SPR) methods for small molecules, antibodies and peptides with proteins, cells and lipid membranes. Kinetic Discovery offers customers the most advanced methods and technology for rapid and reliable fragment screening to enable hit discovery. The company's scientists are recognised world leaders in applying SPR screening to membrane proteins, such as GPCRs. Kinetic Discovery is a University of Dundee spin-out company, operating in Dundee, Scotland, UK.

Contact
College Hill
Lynne Trowbridge, Katie Odgaard, Karen Manser
+44 (0)20 7866 7861
Karen.Manser@collegehill.com


For media enquiries contact:
Roddy Isles
Head, Press Office
University of Dundee
Nethergate, Dundee, DD1 4HN
TEL: 01382 384910
E-MAIL: r.isles@dundee.ac.uk
MOBILE: 07800 581902